美股市場個股詳情
VRTX 福泰製藥
- 468.130
- +3.570+0.77%
收盤價 11/29 13:00 (美東)
- 486.850
- +18.720+4.00%
盤後 17:01 (美東)
1205.57億總市值-246384市盈率TTM
470.930最高價462.330最低價77.06萬股成交量463.600今開464.560昨收3.61億成交額0.30%換手率33.70市盈率(靜)2.58億總股本519.88052周最高7.71市淨率1202.11億流通值347.51052周最低--股息TTM2.57億流通股519.880歷史最高--股息率TTM1.85%振幅7.250歷史最低468.422平均價1股每手
關於福泰製藥公司
福泰製藥股份有限公司是一家全球性的生物技術公司，致力於發現、開發、製造和商業化用於嚴重疾病患者的小分子藥物。該公司專注於開發和商業化治療囊性纖維化、感染性疾病(包括流感和細菌感染等病毒感染)、自身免疫性疾病(如類風溼關節炎)、癌症、炎症性腸病和神經系統疾病(包括疼痛和多發性硬化症)的療法。
公司介紹
公司代碼VRTX
公司名稱福泰製藥
上市日期1991/07/04
發行價格13.75
成立日期1989
CEODr. Reshma Kewalramani, M.D.
所屬市場納斯達克
員工數量5400
年結日12-31
公司地址50 Northern Avenue
城市Boston
省份麻塞諸塞州
國家美國
郵編02210
電話1-617-341-6100
董事高管
- 姓名
- 職務
- 年薪
- Dr. Reshma Kewalramani, M.D.
- Director, President and Chief Executive Officer
- 2059.44萬
- Dr. Ourania Tatsis
- Executive Vice President and Chief Regulatory and Quality Officer
- --
- Jonathan Biller
- Executive Vice President and Chief Legal Officer
- --
- Dr. E Morrow Atkinson, III, PhD
- Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations
- --
- Kristen Ambrose
- Senior Vice President and Chief Accounting Officer
- --
- Carmen Bozic
- Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
- --
- Stuart A. Arbuckle
- Executive Vice President and Chief Operating Officer
- 899.89萬
- Dr. David Altshuler
- Executive Vice President, Global Research and Chief Scientific Officer
- 654.11萬
- Charles F. Wagner, Jr
- Executive Vice President and Chief Financial Officer
- 737.18萬
- Amit K. Sachdev, J.D.
- Executive Vice President and Chief Patient and External Affairs Officer
- --
- Dr. Jeffrey M Leiden, PhD
- Executive Chairman of the Board
- 659.53萬
- Suketu Upadhyay
- Independent Director
- 54.47萬
- Lloyd A. Carney
- Independent Director
- 55.98萬
- Diana L. McKenzie
- Independent Director
- 55.31萬
- Nancy A. Thornberry
- Independent Director
- 40.77萬
- Michel Lagarde
- Independent Director
- 44.91萬
- Bruce I. Sachs
- Lead Independent Director
- 60.00萬
- Dr. Alan M. Garber, M.D.,PhD
- Independent Director
- 53.76萬
- Dr. Sangeeta N. Bhatia, PhD
- Independent Director
- 55.03萬
- Dr. Jennifer Schneider, M.D.
- Independent Director
- --
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
